Now available: SARS-CoV-2 Spike RBD

17 Nov, 2020


no comments

Now available: SARS-CoV-2 Spike RBD antigen from Advanced ImmunoChemical.

Our recombinant SARS-CoV-2 Spike RBD antigen has been produced in mammalian cells Purity is over 95%. It is provided in lyophilized form and can be used in the development of COVID-19 serology (antibody) tests.

SARS-CoV-2 Spike RBD is a fragment Arg319-Phe541 of the spike surface glycoprotein and contains the receptor binding domain of the virus. The protein contains a C-terminal His6-tag.

SARS-CoV-2 Nucleoprotein is a full-length nucleocapsid expressed in E. coli. Purity of the protein is over 95%.

In addition, we provide monoclonal antibodies specific to different Ig classes: IgM, IgG and IgA which can be used as secondary antibodies in serology assays.

COVID-19-related Antibodies and Antigens, product details:

SARS-Cov-2 Spike Receptor Binding Domain (RBD), mammalian recombinant

SARS-CoV-2 Nucleoprotein, recombinant

Monoclonal Mouse Anti-IgA, in vitro

Monoclonal Mouse Anti-human IgM, in vitro

Monoclonal Mouse Anti-human IgG, in vitro

At Advanced ImmunoChemical, Inc., we provide ISO-9001 manufactured antibodies, viral antigens, recombinant proteins, and PCR enzymes. Our company is an important critical raw material supplier to the IVD industry,academia, and government.

Advanced ImmunoChemical is open and business continues as normal. We confirm that we are continuing to supply our products as normal and do not foresee any significant disruption in product availability or ship schedules. However, circumstances can change. Please know we will continue to follow developments and do our best to advise you as soon as possible if the situation changes.

Please visit our website:

Skip to toolbar